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Food Protein-Induced Gastrointestinal
Syndromes in Identical and Fraternal
Twins
Tetsuo Shoda1,2, Atsushi Isozaki1 and Yutaka Kawano1
ABSTRACT
Background: It has been suggested that gene-environmental interactions play crucial roles in the develop-
ment of allergy, especially in early life. Analysis of twin cases may provide novel insights into the pathogenesis
and pathophysiology of allergy. Though several studies have indicated the importance of a genetic contribution
to the expression of allergic diseases based on twin analyses, very few data are available regarding twins with
Food Protein-Induced Gastrointestinal Syndrome (FPIGS). Two pairs of identical and fraternal twins with
FPIGS are presented.
Case Summary: The twins were born with no abnormalities and fed breast milk and supplemental formula.
The identical twins developed vomiting and bloody stool simultaneously. The fraternal twins developed pro-
longed vomiting and loose stools at different times. Since their symptoms disappeared with when formula feed-
ing was stopped, the symptoms were thought to indicate the presence of an allergy to cow’s milk. The clinical
symptoms and laboratory findings of the four patients were highly suggestive of FPIGS. The identical and fra-
ternal twins showed very similar symptoms, including their onset and clinical courses. However, a substantial
clinical disparity existed in the clinical features of the two pairs of twins.
Discussion: Comparisons of the twins’ similarities and disparities suggest a profound genetic effect on the
patients’ clinical features, along with individual environmental factors. The prevalence of FPIGS is increasing,
and it is now a major topic of public concern in Japan. Further accumulation of data on twins with FPIGS is
needed to clarify the genetic contributions to this disease.
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ABBREVIATIONS
CM, cow’s milk; MBM, mother’s breast milk; CMF, cow’s milk-based formula; HF, hydrolyzed formula; SBF,
soybean formula; AAF, amino acid-based formula; BW, body weight; SPT, skin prick test; APT, atopy patch
test; LST, lymphocyte stimulation test; OFC, oral food challenge; Pt 1, Patient 1; Pt 2, Patient 2; Pt 3, Patient 3;
Pt 4, Patient 4.
INTRODUCTION
Food hypersensitivity disorders are characterized by
adverse immune responses to normally innocuous
food proteins. Food protein-induced gastrointestinal
syndromes (FPIGS) is a general term encompassing
several gastrointestinal disorders such as food
protein-induced enterocolitis syndrome (FPIES),
proctocolitis, enteropathy and eosinophilic gastroen-
teropathies.1 FPIGS is caused by cell-mediated im-
mune responses against food antigens and is not usu-
ally associated with a detectable IgE antibody. Al-
though each FPIGS syndrome has been established
as a distinct clinical entity, an accurate diagnosis can
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be difficult. Reports on this syndrome are increasing
in Japan,2 but the role of genetics in the etiology of
this syndrome remains unclear. Here, we present two
pairs of identical and fraternal twins exhibiting
FPIGS.
CLINICAL SUMMARY
FIRST TWINS
Identical twins were born after an uneventful preg-
nancy at 37 weeks and 2 days of gestational age; the
twins were delivered during a scheduled caesarean
section because of a previous cesarean section in the
mother. The birth weights of the first (Patient 1; Pt 1)
and second (Patient 2; Pt 2) neonates were 2,438 g
and 2,560 g, respectively. Pt 1 was fed with maternal
breast milk and a supplemental formula from one day
after birth. Pt 1 experienced vomiting, bloody stools,
and lethargy on day eight. Pt 2 was solely fed with
maternal breast milk from day one, with the addition
of supplemental formula from day four. Pt 2 exhibited
similar abdominal symptoms on day seven. Since
their abdominal symptoms disappeared with the in-
terruption of formula feeding and the presence of
other intestinal organic lesions was excluded by de-
tailed examinations, the patients’ abdominal symp-
toms were thought to indicate the presence of an al-
lergy to cow’s milk (CM) based on the presence of
hypereosinophilia and strong lymphocyte transforma-
tion induced by CM antigen. Pt 1 was successfully fed
with a hydrolyzed formula, but Pt 2 was intolerant of
this formula and required an amino acid-based for-
mula. Pt 2 exhibited repeated vomiting, diarrhea and
lethargy beginning six hours after the ingestion of 10
mL of hydrolyzed formula, and an elevated neutrophil
count was observed. Thereafter, both patients grew
well and showed no developmental abnormalities. As
they had no allergic symptoms to other foods, includ-
ing soy, rice, and wheat, an oral milk challenge was
performed at the age of six months. The results of
the food challenge tests were positive. The patients
exhibited vomiting (only Pt 2), diarrhea, lethargy and
elevated peripheral neutrophil counts (over 3,500
μL) beginning about three to six hours after the in-
gestion of 20 mL of CM formula. They fulfilled two or
three of the five diagnostic criteria for FPIES. As a re-
sult, the use of therapeutic formula was continued for
several months.
SECOND TWINS
Fraternal twins were born after an uneventful preg-
nancy at 37 weeks of gestational age; the twins were
delivered during a scheduled cesarean section be-
cause of a previous cesarean section in the mother.
The birth weights of the first (Patient 3; Pt 3) and sec-
ond (Patient 4; Pt 4) neonates were 2,460 g and 2,625
g, respectively. The neonates did not exhibit any res-
piratory or circulatory distress and were fed with ma-
ternal breast milk and supplemental formula from day
one. At the age of seven weeks, Pt 3 developed pro-
longed vomiting and loose stools and was hospital-
ized at a local children’s hospital at the age of eight
weeks. His symptoms were promptly alleviated by
the discontinuation of formula feeding, and a detailed
examination disclosed no organic lesions in his intes-
tine; the patient was able to tolerate soybean milk. Pt
4 exhibited similar symptoms at the age of ten weeks,
although the symptoms were somewhat milder symp-
toms than those of Pt 3. Similar to Pt 3, Pt 4 was also
able to tolerate soybean milk. In addition to their
clinical findings, positive fecal eosinophils in Pt 3 and
hypereosinophilia in Pt 4 together with positive lym-
phocyte proliferation test results for CM antigen sug-
gested that both patients were allergic to CM. At the
age of three months, an oral milk challenge showed
negative results. Thereafter, both patients were able
to tolerate the previously used formula, and they both
exhibited normal growth and development.
PATHOLOGICAL FINDINGS
The laboratory data for the four patients are shown in
Table 1, 2. Serum samples from the patients were
analyzed for specific IgE antibody titers against CM
using the Phadia CAP-RAST system. The lower de-
tection limit of this system is 0.35 UAmL. A skin
prick test (SPT) was performed using CM formula.
Isotonic saline and 0.1% histamine were the negative
and positive controls, respectively. These solutions
were applied to the forearm. The reactions were de-
termined after 15 minutes, and all the patients were
negative. An atopy patch test (APT) was also per-
formed using one drop (50 μL) of CM formula in ref-
erence to a previous report.3 Isotonic saline was used
as the negative control. These solutions were applied
to the infants’ backs. The patches were removed at 48
hours, and the results were determined at 72 hours
and 1 week by a dermatologist. A lymphocyte stimu-
lation test (LST), which has been shown to be useful
for identifying subjects with cell-mediated food al-
lergy,4 was performed in all the patients. The results
were shown as the S.I.F. (stimulation index measured
using flow cytometry). The oral food challenge
(OFC) was undertaken with informed consent. In-
creasing doses (1.0, 5.0, 10, 20, and 30 mL) of CM for-
mula were successively administered at 3-hour inter-
vals. A positive OFC was determined by the presence
of vomiting, diarrhea, bloody stools, and lethargy be-
ginning two to twenty-four hours after ingestion and
accompanied by a characteristic rise in the neutrophil
count, in reference to the FPIES criteria.1,5,6
On the day of onset, the numbers of leukocytes
and neutrophils were elevated, but systemic inflam-
mation, as indicated by the C-reactive protein level,
and imminent acidosis were absent in all the patients.
CM-specific IgE was undetectable, and SPT and APT
were negative in all the patients. However, LST
against two major allergens in CM, α-casein and β-
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Table　1　Laboratory data of the day of their onset
Patient 1 (girl) Patient 2(girl) Patient 3 (boy) Patient 4 (girl)
WBC (/μl) 13,300 19,700 22,700 8,000
Neutrophil (%) 52 60 60.5 46
Eosinophil (%) 1 5 0 5
Hb (g/dl) 11.3 12.6 10.1 11.2
Plt (×104/μl) 59.8 45.4 50.6 37.6
AST (IU/L) 21 18 45 15
ALT (IU/L) 6 6 62 12
γ GTP (IU/L) 31 1 2 24
CRP (mg/dl) 0.2 0.1 0.1 0.82
Blood gas analysis (vein)
pH 7.344 7.342 7.462 7.334
pCO2 24.9 33.1 43.9 33.9
HCO3 17.4 17.6 21.7 23.4
B.E. -4.4 -7.5 -2.0 -2.3
Antigen specifi c lymphocyte stimulation test
α-casein (S.I.F.) 2,022 3,648 1,456 260
β-lactoglobulin (S.I.F.) 914 880 731 265
α casein (cut off <330), β-lactoglobulin (cut off <170).
Examination was carried out at day 18 (patient 1, 2), at 3 months (patient 3, 4) of age.
Results were showed as S.I.F. (stimulation index measured by fl ow cytometry). The measurements were performed by Dr. M. Kimura 
from Shizuoka Children’s Hospital.
Table　2　Comparison of the clinical features of the four patients
Patient 1 (girl) Patient 2 (girl) Patient 3 (boy) Patient 4 (girl)
Onset day Day8 Day7 Day52 Day72
Maternal breast milk From day1 From day1 From day1 From day1
Formula From day1 From day4 From day1 From day1
Therapeutic formula Hydrolyzed Amino-acid based Soy Soy
Symptoms Vomit
Bloody stool
Vomit
Bloody stool
Vomit
Diarrhea
Vomit
Diarrhea
Max WBC (/μl) 13,300 19,700 22,700 11,000
Max neutrophil (%) 52 60 60.5 46
Max eosinophil (%) 21 15 3.8 9
Max CRP (mg/dl) 0.2 1.6 0.1 0.1
CM-specifi c IgE (UA/ml) <0.34 <0.34 <0.34 <0.34
Skin prick test Negative Negative Negative Negative
Patch test Negative Negative Negative Negative
Fecal eosinophil Negative Positive Positive Negative
Stool culture Negative Negative Negative Negative
Age of tolerance Not yet Not yet 7 months 3 months
lactoglobulin, were consistently positive in all the pa-
tients.
DISCUSSION
Non-IgE-mediated gastrointestinal food hypersensi-
tivity, including FPIGS, is most commonly induced
by CM protein and often manifests as vomiting and
diarrhea with occasional progression to shock.1,5,6
The gold standard for diagnosis is the reappearance
of symptoms after reintroduction and the disappear-
ance of symptoms after withdrawal of the causative
formula. In our patients, the gastrointestinal symp-
toms improved after the discontinuation of the causa-
tive formula at the beginning of the diseases, al-
though the reintroduction of the CM formula did not
elicit such symptoms several months later. Since the
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Fig.　1　Clinical course of identical twins.
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diagnosis of FPIGS relies on the medical history,
clinical features, and exclusion of other causes, the
clinical symptoms and laboratory findings of the four
patients are highly suggestive of FPIGS.
Despite the negative CM-specific IgE antibody find-
ings obtained at the time of early onset in all the pa-
tients, Pts 1, 2, and 3 became positive at an age of
twelve months. At that time, the SPT results were still
negative in all the patients. Exactly how IgE was re-
lated to their symptoms remains unclear. Although a
previous report has shown that APT is a useful tool
for the diagnosis of FPIES,3 the APT was negative in
all our patients. These results might have been false-
negatives because of the poor milk antigen quantity.
Since our patients were neonates or young infants
when the APT was performed, the usefulness of APT
during early life remains to be determined. Although
its diagnostic value has not yet been confirmed, a
high LST value tends to result in the slow acquisition
of tolerance. The intensity of the LST may be corre-
lated with the disease severity, as suggested by the
findings for our patients, although the accumulation
of further data is needed to confirm this hypothesis.
A comparison of the clinical features of the two
pairs of twins is shown in Table 2, Figure 1, 2. In gen-
eral, Pt1, 2 and Pt 3, 4 showed very similar symp-
toms, including their onset and clinical courses. How-
ever, a substantial clinical disparity exists in the clini-
cal features of the two pairs of twins. This finding sug-
gests that environmental influences shared by each
pair of twins may have contributed to the similarity of
their clinical features in addition to their genetic ho-
mogeneity, although monozygotic twins have theo-
retically twice as many similar genes as dizygotic
twins. These findings agree with those of previous re-
ports in which genetic and environmental mecha-
nisms were shown to affect allergic diseases pro-
foundly in early life.7
Despite their general resemblance, each pair of
twins still exhibited some differences. The severity
was quite different between the fraternal twins, even
though their initial symptoms were the same. Regard-
ing the antigen-specific lymphocyte responses to CM
antigen, the identical twins showed strong responses
of similar magnitude, while the fraternal twins exhib-
ited different reactivities. Therefore, we hypothesized
that inheritable traits may have contributed to the
phenotype of these patients, since the identical twins
exhibited a similarity that was not present in the fra-
ternal twins. We also speculated that a minor modifi-
cation of the phenotype may be provided by the
individual-specific environments. These interpreta-
tions are supported by the findings of Sicherer’s re-
port,8 which compared the concordance and discor-
dance between monozygotic and dizygotic twins. Un-
fortunately, their data concerned peanut allergy, a
typical IgE-mediated food allergy that may be eti-
ologically different from the cell-mediated food hyper-
sensitivity observed in the present FPIGS cases. On
the other hand, a previous report on twins with
FPIGS did not contain any information concerning
this point.9
The incidence of neonate milk allergy has been re-
ported to be 0.21% at institutions providing medical
care for high-risk neonates in Japan,10 and the prob-
ability of both twins developing FPIGS is much lower.
In our hospital, about 550 babies are born every year,
with about 5 pairs of identical twins and 4 pairs of fra-
ternal twins born each year. The presently reported
twins with FPIGS were the only such cases to be
treated in the past 5 years. Both pairs of twins were
affected with FPIGS, a rather rare allergic disease.
This occurrence suggests that both genetic factors
and the intrauterine environment may be crucial fac-
tors in the pathogenesis of FPIGS. In Japan, clinical
reports of FPIGS have increased dramatically since
1995. Before 1995, FPIGS was a very rare disease in
Japan. Thus, not only genetic factors, but also envi-
ronmental factors may play important roles in the
pathogenesis of FPIGS.
Gene-environmental interactions have been sug-
gested to play crucial roles in the development of al-
lergy, especially in early life. Although several studies
have indicated the importance of a genetic contribu-
tion to the expression of allergic diseases based on
analyses of twins,8,11 very little data is available re-
garding twins with FPIGS. The further accumulation
of data on twins with FPIGS is needed to clarify the
genetic contributions to this disease.
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